Research · Sep 3, 2026
[SBRA] Sabra Health Care REIT Thesis 2026: A Skilled-Nursing-Heavy Healthcare REIT Recovers Post-COVID With High Dividend Yield
Sabra Health Care REIT Inc. (NASDAQ: SBRA), headquartered in Tustin, California, is a publicly-traded healthcare REIT specializing in skilled nursing + senior housing + behavioral health + other healthcare real-estate investments operating ~370+ facilities across the US + Canada through triple-net + RIDEA-structure lease arrangements with operating-tenants. Founded in 2010 as a spin-off from Sun Healthcare Group (publicly-traded skilled-nursing operator) — Sabra was created to separate real-estate-investment activities from operating-business activities and provide REIT-structure tax efficiency. Under President & CEO Rick Matros (CEO since 2010 founding, prior CEO of Sun Healthcare + Regency Health Services + selected other companies, ~40+ years skilled-nursing sector experience), the company has grown the investment portfolio from initial Sun-Healthcare-spin-off assets (~$700M+) to ~$5.5-6.5B+ at cost today through strategic acquisitions and portfolio-recycling. FY2025 closes with selected various aggregate revenue ~$0.7-0.75B, normalized FFO per share ~$1.40-1.55, total investment portfolio ~$5.5-6.5B+, ~370+ facilities, net leverage ~5-6x, and ~233M shares outstanding. The first deep-dive — the skilled nursing facility (SNF) + senior housing + behavioral health REIT portfolio — covers the franchise-defining real-estate investment base. Skilled Nursing Facilities (~60-65% of investment value, 270+ SNFs leased to ~30+ operating-tenants) provide 24/7 skilled nursing + rehabilitation + long-term care to Medicare (post-acute short-stay) + Medicaid (long-stay) + self-pay populations; SNF funding mix is ~50-60% Medicaid + ~30-40% Medicare + ~10-15% private/managed-care; triple-net lease structure has tenant paying all operating expenses + rent. Senior Housing (~20-25%) includes independent + assisted + memory care under mix of triple-net + RIDEA-structure leases (RIDEA allows REIT to participate in operating profits/losses). Behavioral Health (~10-15% growing) covers addiction-treatment + mental-health centers benefiting from opioid-crisis demand + mental-health-awareness expansion + Medicaid/commercial behavioral-health coverage growth. Geographic mix broad US + Canadian senior-housing. FY2026 catalyst is SNF tenant operating-performance recovery (dominant value-driver), RIDEA-senior-housing operating results, behavioral-health expansion, tenant credit quality, and selective acquisitions. Competes with Omega Healthcare Investors (OHI, similar scale + skilled-nursing focus), CareTrust REIT (CTRE), Welltower (WELL), Ventas (VTR), Healthcare Realty Trust (HR), National Health Investors (NHI), LTC Properties (LTC). The second deep-dive — the post-COVID skilled-nursing tenant recovery + the rent-coverage + tenant-credit narrative + the dividend-cut history — covers Sabra's most-defining challenge. The post-COVID skilled-nursing crisis (2020-2022) included ~200K+ excess COVID-related deaths in US nursing-home populations, occupancy collapse from ~85% pre-COVID to ~70-75% trough, substantial operator-labor stress (post-COVID labor costs +15-30%+), and tenant-financial stress driving rent-coverage (tenant EBITDARM / Sabra rent) below 1.0x for many tenants. In response, Sabra cut its dividend from $1.80 to $1.20 annual in mid-2020 (-33% cut) — maintained at $1.20 since (~$0.30/quarter, ~6-7% yield). The multi-year recovery has involved tenant-by-tenant restructuring + replacement (Genesis Healthcare acquired by ReNew Health 2024 + other restructurings), ongoing rent collection + forbearance management, and portfolio-diversification reducing skilled-nursing concentration. 2024-2025 recovery: occupancy ~80-85% (still below pre-COVID), Medicare + Medicaid rate increases meaningfully approved, operator-labor-management normalized, rent-coverage recovered toward ~1.3-1.5x average. The rent-coverage narrative is the leading indicator of dividend-coverage + eventual dividend resumption — Matros has guided that dividend could be raised again as recovery completes. FY2026 catalyst is continued SNF occupancy + reimbursement recovery, rent-coverage trend, dividend coverage + possible resumption, tenant-restructuring outcomes. Risks include skilled-nursing recovery stalling, reimbursement-policy adverse changes, tenant bankruptcies, healthcare-REIT cycle pressure. Capital position is moderately-to-elevated-leveraged: net leverage ~5-6x net-debt-to-adjusted-EBITDA (healthcare-REIT industry norm), BB+ to BBB-area credit ratings, senior unsecured notes + revolver + term loans with laddered maturities, $1.20/yr dividend (~6-7% yield, cut from $1.80 in 2020), modest opportunistic buybacks de-prioritized, ~233M shares modestly growing. At ~$16-22 per share, equity value ~$3.7-5.0B and EV ~$6-7.5B, ~10-15x FFO — discount to higher-quality healthcare-REIT peers reflecting skilled-nursing concentration + post-COVID recovery overhang + tenant-credit concerns; ~6-7% dividend yield does most of total-return work. Base case is continued SNF recovery + FFO growth + dividend stable with possible modest resumption + ~10-15% total return; bull case is rapid recovery + occupancy returning to pre-COVID + rent-coverage strengthening + dividend resumption + 15-18x re-rating + 25-40%+ return; bear case is SNF stalls + tenant deterioration + dividend pressure + 7-9x de-rating.